All News

Feb. 17 CbdMD, Inc., Q1 2026 Earnings Call, Feb 17, 2026
Feb. 17 CbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026 PR
Feb. 17 CbdMD, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2025 CI
Feb. 12 CbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results PR
Feb. 02 Cbdmd, Inc.'S Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum CI
Feb. 02 CbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum PR
Jan. 29 CbdMD, Inc. Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways CI
Jan. 29 CbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways PR
Jan. 20 CbdMD : Amendment to Annual Report (Form 10-K/A) PU
Jan. 14 cbdMD announces strategic acquisition of Bluebird Botanicals RE
Jan. 14 CbdMD Announces Strategic Acquisition of Bluebird Botanicals PR
Jan. 13 CbdMD, Inc. acquired assets of Gaia Botanicals, LLC for $1 million. CI
Dec. 19 CbdMD, Inc., Q4 2025 Earnings Call, Dec 19, 2025
Dec. 19 CbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance PR
Dec. 19 CbdMD, Inc. Reports Earnings Results for the Full Year Ended September 30, 2025 CI
Dec. 19 CbdMD, Inc. Announces Closing of $2.25 Million Series C Preferred Stock Private Placement PR
Dec. 19 Investors Hope for Rate Cut Following Subdued Inflation as US Futures Mixed in Friday's Premarket Session MT
Dec. 19 CbdMD Insider Sold Shares Worth $1,276,842, According to a Recent SEC Filing MT
Dec. 19 Wall Street Set to Open Little Changed as Investors Await Home Sales, Consumer Sentiment Data MT
Dec. 19 Investors Hope for Rate Cut Following Subdued Inflation as US Futures Mixed in Friday's Premarket Session MT
Dec. 18 CbdMD, Inc. Auditor Raises 'Going Concern' Doubt CI
Dec. 18 CbdMD, Inc. announced that it has received $2.25 million in funding CI
Dec. 17 CbdMD, Inc. to Host Conference Call to Discuss September 30, 2025, Fourth Quarter and Fiscal Year 2025 Results PR
Dec. 08 CbdMD, Inc. Regains Compliance with NYSE American Listing Standards PR
Nov. 21 CbdMD reports preliminary unaudited fourth quarter results RE
No results for this search